Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy

被引:14
作者
Hak, Sjoerd [1 ,2 ,3 ]
Cebulla, Jana [2 ,3 ]
Huuse, Else Marie [1 ,2 ,3 ]
Davies, Catharina de L. [4 ]
Mulder, Willem J. M. [5 ,6 ]
Larsson, Henrik B. W. [2 ,7 ]
Haraldseth, Olav [1 ,2 ,3 ,8 ]
机构
[1] Norwegian Univ Sci & Technol, MI Lab, N-7034 Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway
[3] Inst Sirkulasjon & Bildediagnost, MR Senteret, N-7491 Trondheim, Norway
[4] Norwegian Univ Sci & Technol, Dept Phys, N-7034 Trondheim, Norway
[5] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, New York, NY USA
[6] Mt Sinai Sch Med, New York, NY 10029 USA
[7] Glostrup Univ Hosp, Diagnost Dept, Funct Imaging Unit, Glostrup, Denmark
[8] St Olavs Univ Hosp, Dept Med Imaging, Trondheim, Norway
关键词
DCE-MRI; Intravital microscopy; Targeted nanoparticles; Targeting kinetics; Vascular targeting; IN-VIVO; ANGIOGENESIS; INTEGRIN; LIPOSOMES; PERFUSION; PEPTIDES; EFFICACY; DTPA; MRI; T-1;
D O I
10.1007/s10456-013-9380-7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In the past two decades advances in the development of targeted nanoparticles have facilitated their application as molecular imaging agents and targeted drug delivery vehicles. Nanoparticle-enhanced molecular imaging of the angiogenic tumor vasculature has been of particular interest. Not only because angiogenesis plays an important role in various pathologies, but also since endothelial cell surface receptors are directly accessible for relatively large circulating nanoparticles. Typically, nanoparticle targeting towards these receptors is studied by analyzing the contrast distribution on tumor images acquired before and at set time points after administration. Although several exciting proof-of-concept studies demonstrated qualitative assessment of relative target concentration and distribution, these studies did not provide quantitative information on the nanoparticle targeting kinetics. These kinetics will not only depend on nanoparticle characteristics, but also on receptor binding and recycling. In this study, we monitored the in vivo targeting kinetics of alpha(v)beta(3)-integrin specific nanoparticles with intravital microscopy and dynamic contrast enhanced magnetic resonance imaging, and using compartment modeling we were able to quantify nanoparticle targeting rates. As such, this approach can facilitate optimization of targeted nanoparticle design and it holds promise for providing more quantitative information on in vivo receptor levels. Interestingly, we also observed a periodicity in the accumulation kinetics of alpha(v)beta(3)-integrin targeted nanoparticles and hypothesize that this periodicity is caused by receptor binding, internalization and recycling dynamics. Taken together, this demonstrates that our experimental approach provides new insights in in vivo nanoparticle targeting, which may proof useful for vascular targeting in general.
引用
收藏
页码:93 / 107
页数:15
相关论文
共 47 条
[21]   Disrupting Established Tumor Blood Vessels An Emerging Therapeutic Strategy for Cancer [J].
McKeage, Mark J. ;
Baguley, Bruce C. .
CANCER, 2010, 116 (08) :1859-1871
[22]   In vivo imaging of siRNA delivery and silencing in tumors [J].
Medarova, Zdravka ;
Pham, Wellington ;
Farrar, Christian ;
Petkova, Victoria ;
Moore, Anna .
NATURE MEDICINE, 2007, 13 (03) :372-377
[23]   Nanoparticle imaging of integrins on tumor cells [J].
Montet, Xavier ;
Montet-Abou, Karin ;
Reynolds, Fred ;
Weissleder, Ralph ;
Josephson, Lee .
NEOPLASIA, 2006, 8 (03) :214-222
[24]   Early in vivo assessment of angiostatic therapy efficacy by molecular MRI [J].
Mulder, Willem J. M. ;
van der Schaft, Daisy W. J. ;
Hautvast, Petra A. I. ;
Strijkers, Gustav J. ;
Koning, Gerben A. ;
Storm, Gert ;
Mayo, Kevin H. ;
Griffioen, Aijan W. ;
Nicolay, Klaas .
FASEB JOURNAL, 2007, 21 (02) :378-383
[25]   MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle [J].
Mulder, WJM ;
Strijkers, GJ ;
Habets, JW ;
Bleeker, EJW ;
van der Schaft, DWJ ;
Storm, G ;
Koning, GA ;
Griffioen, AW ;
Nicolay, K .
FASEB JOURNAL, 2005, 19 (12) :2008-+
[26]   Synthesis and in vitro evaluation of cyclic NGR peptide targeted thermally sensitive liposome [J].
Negussie, Ayele H. ;
Miller, Jenna L. ;
Reddy, Goutham ;
Drake, Steven K. ;
Wood, Bradford J. ;
Dreher, Matthew R. .
JOURNAL OF CONTROLLED RELEASE, 2010, 143 (02) :265-273
[27]  
Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
[28]   Nanoparticle Pharmacokinetic Profiling In Vivo Using Magnetic Resonance Imaging [J].
Neubauer, Anne M. ;
Sim, Hoon ;
Winter, Patrick M. ;
Caruthers, Shelton D. ;
Williams, Todd A. ;
Robertson, J. David ;
Sept, David ;
Lanza, Gregory M. ;
Wickline, Samuel A. .
MAGNETIC RESONANCE IN MEDICINE, 2008, 60 (06) :1353-1361
[29]   Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies [J].
O'Connor, James P. B. ;
Jackson, Alan ;
Parker, Geoff J. M. ;
Roberts, Caleb ;
Jayson, Gordon C. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (03) :167-177
[30]   The biologic basis of in vivo angiogenesis imaging [J].
Ocak, Iclal ;
Baluk, Peter ;
Barrett, Tristan ;
McDonald, Donald M. ;
Choyke, Peter .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :3601-3616